Form 4: GoodRx Director Trevor Bezdek Receives RSU Grant

Director Trevor Bezdek acquired 73,434 restricted stock units in GoodRx Holdings, Inc. as part of an equity compensation grant.

Summary

• Director Trevor Bezdek was granted 73,434 restricted stock units (RSUs) on June 16, 2026.
• Each RSU represents a contingent right to receive one share of Class A common stock.
• The units vest in full on the earlier of the one-year anniversary of the grant date or the 2027 Annual Meeting of Stockholders, subject to continued service.
• Following this transaction, the reporting person directly owns 343,810 shares of Class A common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative filing reflecting standard director compensation practices.

Positives

• Alignment of director interests with long-term shareholder value through equity-based compensation.

Negatives

• None identified; this is a standard equity grant for a director.

Risks

• Vesting is contingent upon the reporting person's continued service to the company.

Future Outlook

The RSUs are scheduled to vest in full on the earlier of June 16, 2027, or the date of the 2027 Annual Meeting of Stockholders.

Industry Context

StockSavvy.ai notes that equity grants to directors are standard corporate governance practices designed to incentivize long-term oversight and alignment with shareholder interests in the digital health and pharmacy benefit management sectors.

Comparison to Industry Standards

• The grant of RSUs to directors is consistent with standard compensation practices for publicly traded technology and healthcare companies.
• The vesting schedule of one year is typical for director equity awards in the U.S. market.

Related Party Transactions

• The filing discloses holdings by various Grantor Retained Annuity Trusts (GRATs) associated with the reporting person and his spouse.

Stakeholder Impact

• Minimal impact on shareholders as this is a routine equity compensation grant.

Next Steps

• Vesting of the 73,434 RSUs on the earlier of June 16, 2027, or the 2027 Annual Meeting of Stockholders.

Key Dates

Keywords

GoodRx, GDRX, Form 4, Insider Transaction, Equity Compensation, Director Ownership